Abstract
Because of the rapid increase in the aging population and the plethora of new pharmacologic treatment options, urogenital atrophy disorders have become a more commonly recognized problem in the female population. With the large number of “baby boomers” reaching the menopausal years, by the year 2000 over one-third of the female population in the US were over the age of 50. Up to 43% of this older population will suffer from symptoms of vaginal dryness and 41% will report dyspareunia. However, it is not only gonadal hormonal changes that impact on the anatomic and physiologic alterations that occur in the urogenital tract and characterize urogenital atrophy; many other factors including chronologic aging, parity, genetic and environmental also impact on pelvic health.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wall, L. The muscles of the pelvic floor. Clin Obstet Gynecol 1993;36(4):910–25.
Semmens JP, Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA 1982;248:445–8.
Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990;75:26S–32S.
Hilsson K, Heimer G. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency — pharmacokinetic and pharmacodynamic study, Maturitas 1992;15121–7.
Fantl JA, Cordoza L, McClish DK. Estrogen therapy in the management of urinary incontinence in post-menopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol 1994;83:12–18.
Cardozo L, Bachmann G, McClish D et al. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722–7.
Brincat M, Versi E, Moniz CF et al. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987;70(1):123–37.
Falconer C, Ekman Orbeberg G, Ulmsten G et al. Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas 1996;24:197–204.
Leiblum S, Bachmann G, Kemmann E. Colburn D, Swartzman L. Vaginal atrophy in the menopausal woman: The importance of sexual activity and hormones. JAMA 1983;249(16):2194.
Norton A. Peggy. Pelvic floor disorders the role of fascia and ligaments. Clin Obstet Gynecol 1993;36(4):926–38.
Rosen RC, Taylor JF, Leiblum SR, Bachmann GA. Prevalence of sexual dysfunction in women: Results of a survey of 329 women in an outpatient gynecological clinic. J Sex Marital Ther 1993;19(3):171–88.
Bachmann GA. Urogenital aging: an old problem newly recognized. Maturitas 1995;22:S1–S5.
Brown J, Grady D, Ouslander JG et al. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Obstet Gynecol 1999;94:66–70.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag London Limited
About this chapter
Cite this chapter
Bachmann, G.A., Aptaker-Stirling, L. (2003). Urogenital Atrophy. In: Drutz, H.P., Herschorn, S., Diamant, N.E. (eds) Female Pelvic Medicine and Reconstructive Pelvic Surgery. Springer, London. https://doi.org/10.1007/1-84628-238-1_20
Download citation
DOI: https://doi.org/10.1007/1-84628-238-1_20
Publisher Name: Springer, London
Print ISBN: 978-1-84628-237-9
Online ISBN: 978-1-84628-238-6
eBook Packages: Springer Book Archive